HU174639B - Sposob poluchenija proizvodnogo kasantiliden-piperidina, i antipsikhotichnykh kompozicijj soderzhahhikh ego aktivnym agentom - Google Patents

Sposob poluchenija proizvodnogo kasantiliden-piperidina, i antipsikhotichnykh kompozicijj soderzhahhikh ego aktivnym agentom

Info

Publication number
HU174639B
HU174639B HU75SI1494A HUSI001494A HU174639B HU 174639 B HU174639 B HU 174639B HU 75SI1494 A HU75SI1494 A HU 75SI1494A HU SI001494 A HUSI001494 A HU SI001494A HU 174639 B HU174639 B HU 174639B
Authority
HU
Hungary
Prior art keywords
xantylideneopiperidine
derivative
producing
pharmaceutical compositions
active agent
Prior art date
Application number
HU75SI1494A
Other languages
English (en)
Hungarian (hu)
Inventor
Charles L Zirkle
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of HU174639B publication Critical patent/HU174639B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU75SI1494A 1974-11-06 1975-11-03 Sposob poluchenija proizvodnogo kasantiliden-piperidina, i antipsikhotichnykh kompozicijj soderzhahhikh ego aktivnym agentom HU174639B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52121674A 1974-11-06 1974-11-06

Publications (1)

Publication Number Publication Date
HU174639B true HU174639B (hu) 1980-02-28

Family

ID=24075868

Family Applications (1)

Application Number Title Priority Date Filing Date
HU75SI1494A HU174639B (hu) 1974-11-06 1975-11-03 Sposob poluchenija proizvodnogo kasantiliden-piperidina, i antipsikhotichnykh kompozicijj soderzhahhikh ego aktivnym agentom

Country Status (17)

Country Link
JP (1) JPS5826754B2 (fi)
AU (1) AU498298B2 (fi)
BE (1) BE835224A (fi)
CA (1) CA1055945A (fi)
CH (1) CH624403A5 (fi)
DE (1) DE2549841A1 (fi)
DK (1) DK139429B (fi)
ES (1) ES442357A1 (fi)
FR (1) FR2290202A1 (fi)
HU (1) HU174639B (fi)
IE (1) IE42137B1 (fi)
IL (1) IL48400A (fi)
LU (1) LU73714A1 (fi)
NL (1) NL7512974A (fi)
NZ (1) NZ179139A (fi)
PH (1) PH12158A (fi)
ZA (1) ZA756550B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357251A1 (fr) * 1976-07-09 1978-02-03 Merck & Co Inc 1-methyl-4-(2-carboxy-1-thioxanthan-9-ylidene)-piperidine
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4089961A (en) * 1976-11-08 1978-05-16 Smithkline Corporation Antipsychotically useful quinolizidylidene derivatives of xanthenes, thioxanthenes and dibenzoxepins
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same
US7060711B2 (en) 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1306376A1 (en) * 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
WO2005003131A1 (en) 2003-06-27 2005-01-13 Janssen Pharmaceutica N.V. Tricyclic delta opioid modulators
AU2005335481A1 (en) 2004-08-05 2007-04-19 Janssen Pharmaceutica N.V. Tricyclic delta- opioid modulators
EP1833825A1 (en) 2004-12-22 2007-09-19 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
AU2005319059A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
ATE432279T1 (de) 2004-12-22 2009-06-15 Janssen Pharmaceutica Nv Tricyclische delta-opioid-modulatoren
MX2007008286A (es) 2005-01-06 2007-11-12 Johnson & Johnson Moduladores delta-opioides triciclicos.
TW200716134A (en) 2005-06-16 2007-05-01 Janssen Pharmaceutica Nv Tricyclic opioid modulators
CA2664345A1 (en) 2006-09-29 2008-04-03 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260070A (fi) * 1960-02-25
NL283292A (fi) * 1961-09-29
DE1670118A1 (de) * 1966-07-22 1970-11-05 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
JPS5018478A (fi) * 1973-05-17 1975-02-26

Also Published As

Publication number Publication date
DK139429C (fi) 1979-08-06
ES442357A1 (es) 1977-04-01
IL48400A0 (en) 1976-01-30
NZ179139A (en) 1978-04-28
NL7512974A (nl) 1976-05-10
FR2290202A1 (fr) 1976-06-04
FR2290202B1 (fi) 1980-05-23
PH12158A (en) 1978-11-10
IE42137L (en) 1976-05-06
LU73714A1 (fi) 1976-06-11
AU8624775A (en) 1977-05-05
JPS5826754B2 (ja) 1983-06-04
DE2549841C2 (fi) 1988-07-07
DK139429B (da) 1979-02-19
BE835224A (fr) 1976-05-04
AU498298B2 (en) 1979-03-01
ZA756550B (en) 1976-09-29
IL48400A (en) 1979-01-31
IE42137B1 (en) 1980-06-04
CH624403A5 (en) 1981-07-31
CA1055945A (en) 1979-06-05
DK495775A (fi) 1976-05-07
JPS5170768A (fi) 1976-06-18
DE2549841A1 (de) 1976-05-13

Similar Documents

Publication Publication Date Title
HU173557B (hu) Sposob poluchenija 3-amino-indazol-karbonovojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU174325B (hu) Sposob poluchenija proizvodnykh benzojjnojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU175875B (en) Process for producing 4-bracket-monoalkyl-amino-bracket closed-benzoic acids, esters and pharmaceutically acceptable salts thereof, and pharmaceutical compositions of hypolipidemic activity containing them as active agents
HU174639B (hu) Sposob poluchenija proizvodnogo kasantiliden-piperidina, i antipsikhotichnykh kompozicijj soderzhahhikh ego aktivnym agentom
HU172820B (hu) Sposob poluchenija proizvodnyih benzotiofena i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU171219B (hu) Sposob poluchenija azolil-amidinov i gerbicidnye kompozicii soderzhahhie ikh aktivnym agentom
HU174102B (hu) Sposob poluchenija novykh proizvodnykh 6-d-skobka-skobka zakryta-al'fa-amino-al'fa-skobka-p-acetoksi-fenil-acetamido-skobka zakryta-penam-3-karbonovojj kisloty s antibakterial'nojj aktivnost'ju
HU174927B (hu) Sposob poluchenija proizvodnykh 1-benzazolilalkil-4-zamehhennykh-piperidinov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU173345B (hu) Sposob poluchenija zamehhennykh proizvodnykh propan-2-ola, ikh slozhmykh efirov s nikotinovojj kislotojj i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU173950B (hu) Sposob poluchenija al'fa-al'fa-dvoezamehhennykh proizvodnykh uksusnojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU172659B (hu) Sposob poluchenija proizvodnykh tiazolidina i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU174129B (hu) Sposob poluchenija farmacevticheskikh kompozicijj s antibioticheskojj aktivnoct'ju
HU173308B (hu) Sposob poluchenija proizvodnykh amino-propanola i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU174010B (hu) Sposob poluchenija 1-alkil-2-skobka-fenoksimetil-skobka zakryta-5-nitro-imidazolov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU171120B (hu) Sposob poluchenija proizvodnykh 2-karbalkoksiamino-5-skobka-6-skobka zakryta-fenil-sul'foniloksi-benzimidazola i antigel'mintichnykh kompozicijj soderzhahhikh takie materialy
HU173881B (hu) Sposob poluchenija n-skobka-1h-benzimidazol-2-il-skobka zakryta-karbamatov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
IL46725A0 (en) Derivative of gentamine and its salts,process of preparation and pharmaceutical compositions
HU174981B (hu) Sposob poluchenija n-skobka-1-allil-2-pirrolidilmetil-skobka zakryta-2,3-dimetoksi-5-sul'famoil-benzamida i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU174097B (hu) Sposob poluchenija proizvodnykh fenolefirov dvoe-zamehhennykh 3-amino-2-gidroksipropanom i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HU173952B (hu) Sposob poluchenija novykh beta-laktam antibiotikov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
ZA752863B (en) Active derivatives of methylemaine, therapeutic compositions containing the same and processes for preparing the said derivatives and compositions
HU174882B (hu) Sposob poluchenija proizvodnykh 1,12-metanooksimetano-indolo-kvadratnaja skobka-2,3-a-kvadratnaja skobka zakryta-kinolizina i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
IL46780A0 (en) Indolylacetic acid derivatives,process for their manufacture and pharmaceutical preparations containing these compounds
HU171537B (hu) Sposob poluchenija novykh slozhnykh efirov 5-n-butil-piridin-2-karbonovojj kisloty i kompozicijj soderzhahhikh ikh aktivnym agentom
HU173305B (hu) Sposob poluchenija novykh proizvodnykh penam-karbonovojj-kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee